CD3 Aptamers Promote Expansion and Persistence of Tumor-Reactive T Cells for Adoptive T Cell Therapy in Cancer

To identify CD3-specific T cell agonists, several RNA aptamers were selected against CD3 using SELEX combined with high-throughput sequencing.